Bruin Biometrics Release: OrthoSonos Device To Be Revealed During AAOS Shows Promise Detecting Early-Stage Osteoarthritis

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Clinical studies using Bruin Biometrics’ OrthoSonos device show promising trends in the detection of early stage osteoarthritis (OA) that could lead to better treatments. OrthoSonos is being revealed to a select group of physicians at an invite-only event during AAOS on March 13th.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC